Healthcare -
Biotechnology - NASDAQ - US
$ 1.277
-5.41 %
$ 148 M
Market Cap
-14.19
P/E
CHRS - OPERATING EXPENSES
Operating Expenses CHRS - Coherus BioSciences, Inc.
301 M
LAST VALUE
-24.78%
2 YEAR CAGR
8.08%
5 YEAR CAGR
22.77%
10 YEAR CAGR